The nation of Zimbabwe has declined a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential information.
This move became public after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
A government representative has since stated that the United States was demanding access to genetic material for research and commercial purposes but refused to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to secure a agreement suitable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Context
This development follows a similar case in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were raised about the safety of Kenyans' health data.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.
Based on reports, Sixteen African countries have to date signed these new agreements, representing over $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be accessible to our citizens if a new pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks already set up through the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage continued dialogue with our US partners on how future co-operation could be designed in a manner that respects the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that talks must proceed considering much of the nation's HIV programmes were funded by external financing.
"Where specific concerns exist, including those involving information security or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
The situation underscores the complex tensions between accepting much-needed foreign assistance and protecting national sovereignty in an increasingly data-driven world.